TUHURA BIOSCIENCES, INC.

Profile

Company Names

TUHURA BIOSCIENCES, INC.
MORPHOGENESIS INC

Addresses

10500 UNIVERSITY CENTER DRIVE, TAMPA, FL 33612

10500 UNIVERSITY CENER DRIVE, SUITE 110, TAMPA, FL 33612

10500 UNIVERSITY CENTER DRIVE, SUITE 110, TAMPA, FL 33612

4613 N CLARK AVENUE, TAMPA, FL 33614

Phone Numbers

813-875-6600
18138756600
8138756600
813-288-0014

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

FLORIDA

Total Amount Raised:

$22,899,949.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-12-11 
$1,665,000.00 
$15,000,000.00 
$13,335,000.00 
Debt 
5
2022-06-24 
$9,101,001.00 
$20,000,000.00 
$10,898,999.00 
Equity 
4
2021-10-29 
$5,100,000.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2020-10-28 
$3,830,130.00 
$11,000,000.00 
$7,169,870.00 
Equity 
2
2019-06-20 
$495,000.00 
$15,000,000.00 
$14,505,000.00 
 
1
2017-08-11 
$2,708,818.00 
$15,000,000.00 
$12,291,182.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
BERGMANN 
DIRECTOR
JAMES 
 
BIANCO 
EXECUTIVE OFFICER, DIRECTOR
GRAHAME 
 
COOK 
DIRECTOR
DAN 
 
DEARBORN 
EXECUTIVE OFFICER
DANIEL 
 
DEARBORN 
EXECUTIVE OFFICER
JOSEPH 
 
ERRICO 
DIRECTOR
DAVID 
 
LAWMAN 
DIRECTOR
MICHAEL 
 
LAWMAN 
DIRECTOR, EXECUTIVE OFFICER
MICHAEL 
JOHN 
LAWMAN 
EXECUTIVE OFFICER, DIRECTOR
PATRICIA 
 
LAWMAN 
EXECUTIVE OFFICER, DIRECTOR
PATRICIA 
DIANNE 
LAWMAN 
EXECUTIVE OFFICER, DIRECTOR
ALAN 
 
LIST 
DIRECTOR
MICHAEL 
 
SHAMBLOTT 
EXECUTIVE OFFICER
SCOTT 
 
SLAYTON 
EXECUTIVE OFFICER
PETER 
 
STAATS 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2023-12-11 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-06-24 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2021-10-29 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2019-06-20 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2017-08-11 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2017-08-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PAULSON INVESTMENT COMPANY LLC
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
NONE
NONE
SKYWAY CAPITAL MARKETS, LLC
NONE
NONE
PAULSON INVESTMENT COMPANY, LLC
PAULSON INVESTMENT COMPANY, LLC
SKYWAY CAPITAL MARKETS, LLC
SKYWAY CAPITAL MARKETS, LLC
PAULSON INVESTMENT COMPANY, LLC